These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31024917)

  • 1. Interest of Pet Imaging in Multiple Myeloma.
    Jamet B; Bailly C; Carlier T; Touzeau C; Nanni C; Zamagni E; Barré L; Michaud AV; Chérel M; Moreau P; Bodet-Milin C; Kraeber-Bodéré F
    Front Med (Lausanne); 2019; 6():69. PubMed ID: 31024917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Developments in Myeloma Treatment and Response Assessment.
    Kraeber-Bodéré F; Jamet B; Bezzi D; Zamagni E; Moreau P; Nanni C
    J Nucl Med; 2023 Sep; 64(9):1331-1343. PubMed ID: 37591548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New Perspectives Offered by Nuclear Medicine for the Imaging and Therapy of Multiple Myeloma.
    Mesguich C; Zanotti-Fregonara P; Hindié E
    Theranostics; 2016; 6(2):287-90. PubMed ID: 26877786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Imaging for Therapeutic Assessment and Minimal Residual Disease Detection in Multiple Myeloma.
    Jamet B; Zamagni E; Nanni C; Bailly C; Carlier T; Touzeau C; Michaud AV; Moreau P; Bodet-Milin C; Kraeber-Bodere F
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective Comparison of 18F-Choline Positron Emission Tomography/Computed Tomography (PET/CT) and 18F-Fluorodeoxyglucose (FDG) PET/CT in the Initial Workup of Multiple Myeloma: Study Protocol of a Prospective Imaging Trial.
    Mesguich C; Hulin C; Latrabe V; Asselineau J; Bordenave L; Perez P; Hindie E; Marit G
    JMIR Res Protoc; 2020 Sep; 9(9):e17850. PubMed ID: 32909953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma.
    Cengiz A; Arda HÜ; Döğer F; Yavaşoğlu İ; Yürekli Y; Bolaman AZ
    Turk J Haematol; 2018 Aug; 35(3):175-180. PubMed ID: 29806594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F-18 FDG uptake of bone marrow on PET/CT scan: it's correlation with CD38/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma.
    Ak I; Gulbas Z
    Ann Hematol; 2011 Jan; 90(1):81-7. PubMed ID: 20690019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [
    Lapa C; Schreder M; Schirbel A; Samnick S; Kortüm KM; Herrmann K; Kropf S; Einsele H; Buck AK; Wester HJ; Knop S; Lückerath K
    Theranostics; 2017; 7(1):205-212. PubMed ID: 28042328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of [
    Stolzenburg A; Lückerath K; Samnick S; Speer M; Kneer K; Schmid JS; Grigoleit GU; Hofmann S; Beer AJ; Bunjes D; Knop S; Buck AK; Einsele H; Lapa C
    Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1694-1704. PubMed ID: 29610955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of [
    Sachpekidis C; Merz M; Raab MS; Bertsch U; Weru V; Kopp-Schneider A; Jauch A; Goldschmidt H; Dimitrakopoulou-Strauss A
    EJNMMI Res; 2021 Oct; 11(1):100. PubMed ID: 34628525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multitracer PET/CT with [
    Garrastachu Zumarán P; García Megías I; Mangas Losada M; Mendoza Melero A; Villanueva Torres A; Boulvard Chollet X; Romero Robles L; Hernández Pérez PM; Ramírez Lasanta R; Delgado Bolton RC
    Diagnostics (Basel); 2023 Apr; 13(9):. PubMed ID: 37174961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG-PET in the evaluation of myeloma in 2012.
    Bodet-Milin C; Eugène T; Bailly C; Lacombe M; Frampas E; Dupas B; Moreau P; Kraeber-Bodéré F
    Diagn Interv Imaging; 2013 Feb; 94(2):184-9. PubMed ID: 23287424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study.
    Fonti R; Pace L; Cerchione C; Catalano L; Salvatore B; De Luca S; Pane F; Salvatore M; Del Vecchio S
    Clin Nucl Med; 2015 Apr; 40(4):303-8. PubMed ID: 25608167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation.
    Patriarca F; Carobolante F; Zamagni E; Montefusco V; Bruno B; Englaro E; Nanni C; Geatti O; Isola M; Sperotto A; Buttignol S; Stocchi R; Corradini P; Cavo M; Fanin R
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1068-73. PubMed ID: 25754658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
    Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
    Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose Metabolism Quantified by SUVmax on Baseline FDG-PET/CT Predicts Survival in Newly Diagnosed Multiple Myeloma Patients: Combined Harmonized Analysis of Two Prospective Phase III Trials.
    Michaud-Robert AV; Zamagni E; Carlier T; Bailly C; Jamet B; Touzeau C; Moreau P; Kraeber-Bodere F; Nanni C; Bodet-Milin C
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32899991
    [No Abstract]   [Full Text] [Related]  

  • 18. 18F-FDG, 11C-Methionine, and 68Ga-Pentixafor PET/CT in Patients with Smoldering Multiple Myeloma: Imaging Pattern and Clinical Features.
    Zhou X; Dierks A; Kertels O; Kircher M; Schirbel A; Samnick S; Buck AK; Knorz S; Böckle D; Scheller L; Messerschmidt J; Barakat M; Kortüm KM; Rasche L; Einsele H; Lapa C
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32824832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET/CT in Multiple Myeloma: Beyond FDG.
    Matteucci F; Paganelli G; Martinelli G; Cerchione C
    Front Oncol; 2020; 10():622501. PubMed ID: 33569348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State of the art imaging of multiple myeloma: comparative review of FDG PET/CT imaging in various clinical settings.
    Mesguich C; Fardanesh R; Tanenbaum L; Chari A; Jagannath S; Kostakoglu L
    Eur J Radiol; 2014 Dec; 83(12):2203-2223. PubMed ID: 25308249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.